<DOC>
	<DOCNO>NCT00956956</DOCNO>
	<brief_summary>The goal study evaluate safety tolerability multiple ascend dos PF-04455242 administer orally healthy adult subject . In addition , plasma urine pharmacokinetics multiple ascend dos PF 04455242 administer orally healthy adult subject evaluate . Finally , effect multiple-doses PF-04455242 serum prolactin concentration explore .</brief_summary>
	<brief_title>A Multiple Dose Study To Determine Safety , Tolerability And Pharmacokinetics Of PF-04455242 In Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject without childbearing potential age 21 55 year , inclusive . ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>An investigator subject blind ( sponsor open )</keyword>
	<keyword>multiple dose</keyword>
	<keyword>dose escalation design PF 04455242 match placebo .</keyword>
</DOC>